Early identification of de novo KCNQ2 variants in patients with epilepsy raises prognostic issues toward optimal management. We analyzed the clinical and genetic information from a cohort of patients with de novo KCNQ2 pathogenic variants to dissect genotype-phenotype correlations
PURPOSE: This study characterizes the clinical and genetic features of nine unrelated patients with ...
Background KCNC2 encodes a member of the shaw-related voltage-gated potassium channel family (KV3.2)...
Recent reports have described single individuals with neurodevelopmental disability (NDD) harboring ...
Early identification of de novo KCNQ2 variants in patients with epilepsy raises prognostic issues to...
Background and ObjectivesKCNC2 encodes Kv3.2, a member of the Shaw-related (Kv3) voltage-gated potas...
International audienceBACKGROUND: Early onset epileptic encephalopathies (EOEEs) are dramatic hetero...
Importance Knowing the range of symptoms seen in patients with a missense or loss-of-function varian...
Objective: To characterize the phenotypic spectrum, molecular genetic findings, and functional conse...
Objective: To characterize the phenotypic spectrum, molecular genetic findings, and functional conse...
Among neonatal epileptic syndromes, benign familial neonatal seizures (BFNS) are often due to autoso...
Objective: To advance the understanding of KCNQ2 encephalopathy genotype–phenotype relationships and...
OBJECTIVE: To characterize the neurologic phenotypes associated with COL4A1/2 mutations and to seek ...
Mutations in the KCNQ2 gene encoding for voltage-gated potassium channel subunits have been found in...
PURPOSE: This study characterizes the clinical and genetic features of nine unrelated patients with ...
Background KCNC2 encodes a member of the shaw-related voltage-gated potassium channel family (KV3.2)...
Recent reports have described single individuals with neurodevelopmental disability (NDD) harboring ...
Early identification of de novo KCNQ2 variants in patients with epilepsy raises prognostic issues to...
Background and ObjectivesKCNC2 encodes Kv3.2, a member of the Shaw-related (Kv3) voltage-gated potas...
International audienceBACKGROUND: Early onset epileptic encephalopathies (EOEEs) are dramatic hetero...
Importance Knowing the range of symptoms seen in patients with a missense or loss-of-function varian...
Objective: To characterize the phenotypic spectrum, molecular genetic findings, and functional conse...
Objective: To characterize the phenotypic spectrum, molecular genetic findings, and functional conse...
Among neonatal epileptic syndromes, benign familial neonatal seizures (BFNS) are often due to autoso...
Objective: To advance the understanding of KCNQ2 encephalopathy genotype–phenotype relationships and...
OBJECTIVE: To characterize the neurologic phenotypes associated with COL4A1/2 mutations and to seek ...
Mutations in the KCNQ2 gene encoding for voltage-gated potassium channel subunits have been found in...
PURPOSE: This study characterizes the clinical and genetic features of nine unrelated patients with ...
Background KCNC2 encodes a member of the shaw-related voltage-gated potassium channel family (KV3.2)...
Recent reports have described single individuals with neurodevelopmental disability (NDD) harboring ...